ANCONRIN

What this means for you

Registered since 20 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79346360

Registration number

7082742

Mark type

Stylized text

Filed

22 Mar 2022

Published for opposition

04 Apr 2023

Registered

20 Jun 2023

Attorney of record

Michael W. Piper

Goods and services

• Class 005 — Pharmaceuticals: Vaccines; medicines for human purpose, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations, namely pharmaceutical preparations for the treatment of genetic and immune system diseases and disorders, cancer, ophthalmic diseases and conditions, infectious diseases; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; dietetic beverages and foods adapted for medical use; medical diagnostic reagents; blood for medical purposes

Owner

• SinoCellTech Ltd., CN
• SinoCellTech Ltd., CN
• SinoCellTech Ltd., CN

Prosecution history

• 16 Oct 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
• 25 Sept 2023 — FINAL DISPOSITION NOTICE SENT TO IB
• 25 Sept 2023 — FINAL DISPOSITION PROCESSED
• 20 Sept 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
• 20 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 20 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
• 04 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 04 Apr 2023 — PUBLISHED FOR OPPOSITION
• 15 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 02 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 17 Feb 2023 — NEW REPRESENTATIVE AT IB RECEIVED
• 09 Feb 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 09 Feb 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 09 Feb 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 03 Oct 2022 — REFUSAL PROCESSED BY IB